[
  {
    "ts": "2026-02-24T07:11:14+00:00",
    "headline": "Merck (MRK) Announces Positive Phase 3 SMART Trial Results for ENFLONSIA (Clesrovimab)",
    "summary": "Merck & Co. Inc. (NYSE:MRK) is one of the best value stocks to buy now. On February 19, Merck announced positive second-season findings from the Phase 3 SMART trial evaluating ENFLONSIA (clesrovimab) in infants and children under 2 years of age at increased risk for severe respiratory syncytial virus/RSV. The data focused on vulnerable children, […]",
    "url": "https://finance.yahoo.com/news/merck-mrk-announces-positive-phase-071114911.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "238fa1b5-b212-388e-8af0-a8df5343e603",
      "content": {
        "id": "238fa1b5-b212-388e-8af0-a8df5343e603",
        "contentType": "STORY",
        "title": "Merck (MRK) Announces Positive Phase 3 SMART Trial Results for ENFLONSIA (Clesrovimab)",
        "description": "",
        "summary": "Merck & Co. Inc. (NYSE:MRK) is one of the best value stocks to buy now. On February 19, Merck announced positive second-season findings from the Phase 3 SMART trial evaluating ENFLONSIA (clesrovimab) in infants and children under 2 years of age at increased risk for severe respiratory syncytial virus/RSV. The data focused on vulnerable children, […]",
        "pubDate": "2026-02-24T07:11:14Z",
        "displayTime": "2026-02-24T07:11:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/a6725463d5739606c11f523b1bed2c78",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Merck (MRK) Announces Positive Phase 3 SMART Trial Results for ENFLONSIA (Clesrovimab)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qGPc7Jy.ARlCW.Gb6i8QOQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/a6725463d5739606c11f523b1bed2c78.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gztz0zJ72kmj7UMhOdG1DA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a6725463d5739606c11f523b1bed2c78.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-announces-positive-phase-071114911.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-announces-positive-phase-071114911.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]